Purpose: To describe the diagnosis and treatment of antiphospholipid syndrome as it relates
to spontaneous abortion. Methods: The relative importance of performing tests of …

Sixty percent of recurrent spontaneous abortions are unexplained. Antiphospholipid
syndrome is a multisystem disease with the predominant features of venous and arterial …

Recurrent pregnancy loss in any trimester in nonlupus patients probably is the most
frequently encountered clinical presentation of the primary antiphospholipid syndrome …

Recurrent adverse pregnancy outcome may be the final result of different causes, including
autoimmune diseases, as the Antiphospholipid Syndrome. Antiphospholipid antibodies …

We have studied, prospectively, the incidence of several antiphospholipid antibodies (lupus
anticoagulant, anti-cardiolipin, anti-phosphatidylserine, anti-phosphatidic acid, anti …

Treatment of repeated foetal loss associated with antiphospholipid syndrome was initially
based on immunomodulating therapy such as corticosteroids or intravenous …

Pregnancy loss, often recurrent, is one of the most important clinical manifestations
associated with the primary antiphospholipid syndrome. In these cases, pregnancy wastage …

ABSTRACT Background: Recurrent miscarriage affects 1–2% of women. Recurrent
pregnancy loss (RPL) is the loss of three or more consecutive pregnancies before or during …

Recurrent miscarriage, the loss of three or more consecutive pregnancies affects 1% of
couples trying to conceive. This is significantly higher than that expected by chance alone …

Antiphospholipid antibodies are found in 15% of women with recurrent miscarriage. These
women have only a 10% live birth rate in subsequent pregnancies in which no …